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a b s t r a c t
Skeletal muscle speciﬁcation and morphogenesis during early development are critical for normal
physiology. In addition to mediating locomotion, skeletal muscle is a secretory organ that contributes to
metabolic homeostasis. Muscle is a highly adaptable tissue, as evidenced by the ability to increase
muscle cell size and/or number in response to weight bearing exercise. Conversely, muscle wasting can
occur during aging (sarcopenia), cancer (cancer cachexia), extended hospital stays (disuse atrophy), and
in many genetic diseases collectively known as the muscular dystrophies and myopathies. It is therefore
of great interest to understand the cellular and molecular mechanisms that mediate skeletal muscle
development and adaptation. Muscle morphogenesis transforms short muscle precursor cells into long,
multinucleate myotubes that anchor to tendons via the myotendinous junction. This process requires
carefully orchestrated interactions between cells and their extracellular matrix microenvironment. These
interactions are dynamic, allowing muscle cells to sense biophysical, structural, organizational, and/or
signaling changes within their microenvironment and respond appropriately. In many musculoskeletal
diseases, these cell adhesion interactions are disrupted to such a degree that normal cellular adaptive
responses are not sufﬁcient to compensate for accumulating damage. Thus, one major focus of current
research is to identify the cell adhesion mechanisms that drive muscle morphogenesis, with the hope
that understanding how muscle cell adhesion promotes the intrinsic adaptability of muscle tissue during
development may provide insight into potential therapeutic approaches for muscle diseases. Our
objectives in this review are to highlight recent studies suggesting conserved roles for cell–extracellular
matrix adhesion in vertebrate muscle morphogenesis and cellular adaptive responses in animal models
of muscle diseases.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Proper muscle speciﬁcation and morphogenesis during devel-
opment are critical for adult muscle physiology. In addition, active
homeostasis maintains muscle function despite the normal wear
and tear that occurs with activity. Skeletal muscle is a remarkably
regenerative and adaptable tissue, with muscle hypertrophy
(increase in cell size) and/or hyperplasia (increase in cell number),
occurring in response to exercise or injury. These adaptive cellular
behaviors can be triggered by stimuli (physical or chemical) both
inside the cell and in the microenvironment surrounding cells. A
key fundamental question is how do cells detect changes in their
microenvironment, integrate and transduce these inputs, and
respond with discrete outputs? It is likely that cell–extracellular
matrix (ECM) adhesion complexes play a major role in this process
because: (1) cell–ECM adhesion complexes provide a physical link
between the cytoskeleton and the microenvironment, (2) bi-
directional signaling between cells and their microenvironment
occurs through cell–ECM adhesion complexes, and (3) cell–ECM
adhesion complexes are dynamic. As cellular morphogenetic or
adaptive responses require the perception and integration of
multiple signaling inputs, cell–ECM adhesions may function as a
link between signaling inputs and cellular behaviors. Here, we will
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focus on recent progress in understanding how cell–ECM adhesion
mediates cellular responses during muscle morphogenesis and
disease.
To highlight dynamic roles for cell–ECM adhesions in physiologi-
cal and pathological processes in skeletal muscle tissue, we will focus
on two major themes – connecting signaling/speciﬁcation to normal
muscle morphogenesis via cell–ECM adhesion, and connecting cell–
ECM adhesion to cellular adaptation in muscle diseases. Excellent
recent reviews have extensively documented what is known about
cell–ECM and cell–cell adhesion during muscle development and
disease (Borycki, 2013; Lund and Cornelison, 2013; Thorsteinsdóttir
et al., 2011); thus, we will mainly focus on newer information and
incorporate the concept of the innate ability of muscle tissue to adapt
to changes in its environment. We will begin by providing a brief
introduction to proteins involved in muscle cell–ECM adhesion and
then discuss roles for cell–ECM adhesion components in multiple
stages of muscle morphogenesis, homeostasis, and disease.
Cell adhesion and the muscle extracellular matrix
Tissue morphogenesis and homeostasis require carefully orche-
strated interactions between cells and their ECM microenvironment.
A tissue's characteristics result from the properties and proportions
of its ECM proteins. Thus, the stiffness of bones and the elasticity of
(young) skin result from the biophysical properties of their constitu-
ent ECMs. Within the last two decades it has become clear that the
ECM also modulates cellular signaling by multiple mechanisms. One
way that the ECM modulates cellular signaling is by sequeste-
ring signaling molecules within the matrix (Droguett et al., 2006).
Cell–ECM interactions can also modify cellular responses to signaling.
For example, ECM receptors act as non-canonical co-receptors
that impart speciﬁcity to FGF signaling (Polanska et al., 2009). ECM
receptors are also both modulated and activated by Notch and MAP-
kinase signaling (Karsan, 2008; Yee et al., 2008). Thus, the “ECM
interactome” is ubiquitous and may play a central role in integrating
cellular responses to multiple signaling pathways as well as mechan-
ical stimuli. As morphogenesis and adaptation require the percep-
tion and integration of multiple signaling inputs, cell–ECM adhes-
ions may function to ‘translate’ signaling inputs into discrete cellular
responses.
The muscle extracellular matrix
The structure of mature mammalian muscle ECM has recently
been described in detail (Gillies and Lieber, 2011). In brief, ECM is
found at all spatial levels of muscle: muscle ﬁbers are surrounded
by basement membranes (BMs), ECM surrounds bundles of ﬁbers,
and whole muscles are encased in ECM (Fig. 1). The bridges
between muscle and other tissues, the NMJs and the MTJs, are
also rich in ECM.
Why is it important to understand how the muscle ECM
develops and is maintained? One dramatic demonstration of
muscle ECM function comes from comparing natural ﬁber bundles
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Fig. 1. The muscle ECM. (A) Simpliﬁed cartoon of proteins involved in muscle cell adhesion to the ECM. Multiple transmembrane receptor complexes indirectly link the
intracellular cytoskeleton to the ECM. The BM attaches to the collagen-rich interstitial matrix. (B) Larger size scale view of the organization of muscle ECM. Not only are
individual muscle ﬁbers encased by ECM, but there are also specialized matrices that deﬁne the neuromuscular and myotendinous junctions (NMJ and MTJ, respectively).
(C) A 24 hpf zebraﬁsh embryo stained with phalloidin (red) to visualize actin and an antibody against laminin-111 (green). Side view, anterior left, dorsal top. Note the long
muscle cells (red arrow) that connect to laminin-111 at the myotome boundaries (green arrow). These boundaries will generate the MTJ.
M.F. Goody et al. / Developmental Biology 401 (2015) 75–9176
with groups of ﬁbers dissected away from ECM and tied together.
The groups (without native ECM) bore the same stress as single
muscle ﬁbers whereas the naturally occurring bundles (with ECM)
had a signiﬁcantly higher modulus (Lieber and Ward, 2013; Meyer
and Lieber, 2011). These data strongly argue that the muscle ECM
bears much of the passive load. This would in turn suggest that
many of the clinical symptoms involving range of motion and
stiffness are derived from changes to the ECM (Gillies and Lieber,
2011). Therefore, elucidating how the muscle ECM develops
normally and discovering manipulations that can improve the
muscle ECM in pathological conditions will likely inform efforts to
maintain muscle health and prevent muscle diseases.
Although assembly of the ECM during development is an
especially interesting phenomenon because the ECM has to con-
tinue to function despite being remodeled and reorganized as
animals grow and change, this process is not well understood. We
and others have shown that the ECM changes during muscle
development and regeneration in both zebraﬁsh and mouse
(Bajanca et al., 2004; Bentzinger et al., 2013; Costa et al., 2008;
Deries et al., 2012; Marques and Thorsteinsdóttir, 2013; Snow and
Henry, 2009). These dynamic changes allow the muscle ECM to be
tuned to the morphogenetic or adaptive responses that generate
and maintain this amazing structure. Expression of many cell–ECM
adhesion proteins during muscle development is similar across
vertebrate species. Here, we will highlight how studies that exploit
the advantages of different vertebrate systems provide comple-
mentary insight into ECM modulation of muscle development and
homeostasis.
Extracellular matrix components
The ECM is a meshwork of secreted proteins that are assembled
into a complex network (Frantz et al., 2010) (Fig. 1). There are
many different proteins in the ECM, only the most prominent of
which (proteoglycans and ﬁbrous glycoproteins) will be intro-
duced here. Proteoglycans are heavily glycosylated ECM proteins
which, due to their one or more glycosaminoglycan chains, absorb
water to generate a hydrous gel that resists compressive forces
(Frantz et al., 2010). The glycosaminoglycan chains that covalently
or non-covalently associate with core proteins to form proteogly-
cans are hyaluronan, heparin sulfate, chondroitin sulfate, derma-
tan sulfate, and keratan sulfate. Speciﬁc proteoglycan molecules
include Aggrecan, Decorin, Perlecan, Agrin, and Syndecans. Pro-
teoglycans play roles in regulating both collagen ﬁbrillogenesis
and the movement/activity of signaling molecules through the
ECM (Yoon and Halper, 2005).
The ﬁbrous glycoproteins Fibronectin (Fn) and laminin will be the
main focus of this review, although roles for other ﬁbrous glycopro-
teins in muscle development and disease will be mentioned as well.
Other ﬁbrous glycoproteins include collagens, Vitronectin, Tenascin,
Thrombospondins, Entactin, Nephronectin, and Fibrinogen. Col-
lagens, which are the most abundant protein in the human body,
comprise 1–2% of skeletal muscle tissue (Sikorski, 2001) and main-
tain the structural integrity of tissues. There are 28 types of collagens
in vertebrates and over 40 different collagen-encoding genes in
humans. Different collagen types (ﬁbrillar, globular) generate differ-
ent structures. The tensile strength of the ECM primarily depends
upon the alignment and density of collagens (Kjaer, 2004). Collagen
proteins undergo many post-translational modiﬁcations, including
hydroxylation, glycosylation, assembly into triple helixes, proteolytic
cleavages, and crosslinking.
Fn is an interstitial matrix protein that is perhaps most
renowned for its functions during branching morphogenesis and
cell migration (Davidson et al., 2006; Jiang et al., 2000; Larsen
et al., 2006; Matsui et al., 2007; Roman, 1997; Roman et al., 1991;
Sakai et al., 2003; Trinh and Stainier, 2004). Fn also plays a critical
role in muscle development and repair (Bentzinger et al., 2013;
Snow et al., 2008b). There are 2 forms of Fn: (1) plasma Fn which
circulates in the blood and is globular, and (2) cellular Fn which is
assembled into ﬁbrils that in turn polymerize to form a ﬁbrillar
matrix. Fn ﬁbril formation is regulated on many levels, including
dimerization and Integrin binding, as well as stretch-mediated
uncovering of a cryptic self-binding site (Leiss et al., 2008). The
ability of ﬁbrillar Fn to be stretched up to fourfold by living cells
may be particularly relevant for dynamic cell movements that
occur during development (Erickson, 2002).
Laminin is necessary for the assembly of the BM (Hohenester
and Yurchenco, 2013). BMs are specialized parts of the ECM that
serve a myriad of functions, playing both structural and signaling/
organizational roles. BMs interface with epithelial and endothelial
tissues, surround muscle cells and Schwann cells, and act as
barriers among other functions (Durbeej 2010). As BMs were ﬁrst
described in muscle tissue over a hundred and ﬁfty years ago
(Bowman, 1840), it is not surprising that the ﬁeld of muscle
research has contributed immeasurably to our understanding of
laminin biology. Laminins are cross-shaped heterotrimeric pro-
teins comprised of an alpha, beta, and gamma chain. Five alpha,
four beta, and three gamma chains (Miner and Yurchenco, 2004)
assemble in different combinations to generate the 16 known
laminins (Aumailley et al., 2005) whose names reﬂect their
composition (e.g. laminin-332 is laminin alpha3beta3gamma2).
One way in which laminin function is tailored to particular tissues
is through tissue speciﬁc expression of different laminin chains. In
addition, there are multiple splice variants of laminin chains and
laminin is post-translationally glycosylated (Morita et al., 1985;
Dean et al., 1990; Ranjan et al., 2014). The laminin network in BMs
is attached to the muscle cell by interacting with transmembrane
laminin receptors. Agrin and Perlecan also link laminin to the cell
surface. A meshwork of type IV collagen is linked to the laminin
network by Entactin and heparin sulfate proteoglycans (HSPGs).
The BM is then linked to the ﬁbrous interstitial matrix that is
mainly composed of collagens and proteoglycans (Sanes, 2003;
1982).
Comprehensive reviews describing structures and functions for
these and other ECM molecules are highly recommended for inter-
ested readers (Halper and Kjaer, 2013; Hohenester and Yurchenco,
2013; Mienaltowski and Birk, 2014; Schwarzbauer and DeSimone,
2011; Tzu and Marinkovich, 2008; Yurchenco, 2011).
Extracellular matrix receptors
The ECM is indirectly linked to the intracellular cytoskeleton via
transmembrane receptor complexes (Campbell and Humphries,
2011) (Fig. 1). The extracellular domain of these receptors binds to
ECM proteins. The short cytoplasmic domain is the hub for assembly
of large protein complexes that link to the cytoskeleton. These
receptor complexes are signaling hubs that relay signals bidirection-
ally (Bissell et al., 1982). Signaling from the ECM modiﬁes intracel-
lular signaling, gene expression, and cell morphology; and signals
fromwithin the cell modify the molecular composition and structure
of the ECM. Cell–ECM adhesion complexes also aid in resisting stress
experienced during muscle contraction (Petrof et al., 1993).
Transmembrane Integrin heterodimers function as receptors for
many of the ECM glycoproteins described above, such as collagens,
Fn, and laminins (Campbell and Humphries, 2011). Integrins consist
of an alpha and a beta subunit (e.g. Integrin alpha7beta1) and play
key roles in nearly every cellular process. Integrin receptors can be
promiscuous: certain Integrin heterodimers can bind multiple ECM
proteins, and multiple Integrin heterodimers can bind certain ECM
proteins. Integrin receptors for collagens include Integrins alpha1, 2,
10, or 11 dimerized with Integrin beta1. Integrin receptors for Fn
include Integrins alpha5beta1, alphaIIbbeta3, and alphaVbeta1, 3, 5,
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6, or 8. Laminin-binding Integrin receptors include Integrins alpha3,
6, or 7beta1 and alpha6beta4 (Srichai and Zent, 2010). The many
different isoforms of Integrin receptors and ECM ligands and their
tissue- and temporally-restricted expression imparts speciﬁcity to
Integrin–ECM interactions and signaling. The conformation of
Integrin heterodimers adds another layer of regulation. Integrins
can exist in three conformational states: bent (inactive), primed
(active), and ligand bound (Askari et al., 2009). Integrin conforma-
tional changes can be induced by interactions involving their
cytoplasmic domain (inside-out activation) or extracellular domain
(outside-in activation) (Ginsberg, 2014).
There are also non-Integrin receptors for collagens and laminins
(Bello et al., 2014). Additional laminin receptor complexes that are
critical for skeletal muscle function are the Dystrophin- or Utrophin-
glycoprotein complexes (DGC or UGC, respectively) (Carmignac and
Durbeej, 2012). These complexes also link the ECM to the intracellular
cytoskeleton. Both the DGC and UGC contain the transmembrane
proteins beta-Dystroglycan, Sarcoglycans, and Sarcospan. Alpha-
Dystroglycan binds to laminin. The distinguishing feature between
these complexes is whether Dystrophin or Utrophin anchor the
complexes to actin within the cell. The UGC is somewhat homologous
to the DGC, but is spatially localized to the neuromuscular junction
(NMJ) and myotendinous junction (MTJ) regions of the muscle cell
membrane whereas the DGC is expressed throughout the membrane
(Matsumura et al., 1992; Pearce et al., 1993; Tinsley et al., 1992; Zhao
et al., 1992). In addition to differing spatial localization, the UGC and
DGC differ with regards to anchoring speciﬁc cytoplasmic proteins to
the membrane (Li et al., 2010).
Again, this is a brief overview of ECM receptors and detailed
reviews on transmembrane receptor complexes for ECM ligands
are recommended for additional reading (Campbell and
Humphries, 2011; Hara and Campbell, 2014; Harburger and
Calderwood, 2009).
Cell adhesion to the ECM plays a critical role in segmentation
The ﬁrst step in muscle development is segmentation of the
paraxial mesoderm ﬂanking the notochord into somites, which
give rise to most of musculature in vertebrates (Buckingham et al.,
2003; Hollway and Currie, 2003). Somites in the amniotes and
teleosts studied thus far consist of an outer epithelial layer that
surrounds an inner mesenchymal cell mass (Gossler and Hrabĕ de
Angelis, 1998; Kimmel et al., 1995). Somite formation proceeds in
an anterior to posterior progression during development. Thus,
anterior somites are older than posterior somites. This results in
asynchronous muscle development as well, with anterior seg-
ments differentiating earlier than posterior segments.
As a discussion of how somites are patterned is outside the scope
of this review, wewill concentrate on somite boundary formation and
maturation of somites into myotomes (groups of speciﬁed muscle
ﬁbers). Somites are transient structures. Shortly after somite forma-
tion in amniotes, the ventral aspect of the somite undergoes an
epithelial to mesenchymal transition (EMT) to form the sclerotome
that will give rise to axial cartilage and bones and the syndetome that
will give rise to tendons (Deries et al., 2010; Tozer and Duprez, 2005).
In contrast, the medial and dorsal aspect of the somite remains
epithelial and is termed the dermomyotome. The dermomyotome
will give rise to the primary myotome, to muscle progenitors that
sustain embryonic and fetal growth, and to muscle stem cells that
mediate homeostasis and repair in the adult (Relaix et al., 2005; Ben-
Yair and Kalcheim, 2005; Kassar-Duchossoy et al., 2005; Gros et al.,
2005; Schienda et al., 2006). In zebraﬁsh, the majority of somitic cells
give rise to the primary myotome, with the sclerotome and synde-
tome elements occupying a small proportion of the somite (Kimmel
et al., 1995; Morin-Kensicki and Eisen, 1997). Although zebraﬁsh lack
a dermomyotome per se, there is a population of somitic cells that
gives rise to an external cell layer (ECL) that covers the myotome
(Devoto et al., 2006; Siegel et al., 2013; Stellabotte and Devoto, 2007)
(Fig. 2). The ECL is composed of mitotically active Pax7 expressing
cells that contribute to muscle growth and function in a manner
analogous to the amniote dermomyotome. Thus, although the relative
proportions and exact morphology of these elements (sclerotome,
syndetome, dermomyotome) differ between amniotes and teleosts,
there is largely functional conservation of these somitic subdomains.
There is remarkable conservation of roles for ECM during
muscle development in amniotes and zebraﬁsh despite the differ-
ence in somitic structure. In both amniotes and zebraﬁsh, different
regions of the myotome have distinct matrices (Deries et al., 2012;
Snow and Henry, 2009) (Fig. 2). In amniotes, the dermomyotome
and sclerotome are separated by a distinctive BM in addition to the
BM and Fn-rich matrix present at segment boundaries (Anderson
et al., 2007; Bajanca et al., 2004; 2006; Tosney et al., 1994). In
zebraﬁsh muscle tissue, ECM surrounds muscle ﬁbers and con-
centrates at the boundaries between muscle segments. As muscle
differentiates, the Fn-rich matrix becomes concentrated adjacent
to slow-twitch ﬁbers. This is in contrast to the laminin-rich BM
that concentrates adjacent to both slow-twitch and fast-twitch
muscle ﬁbers. In teleosts, these ECM-rich areas between muscle
segments will mature into MTJs, which are the functional equiva-
lent of mammalian MTJs (Gemballa and Vogel, 2002). Next, we
will focus on how cell–ECM adhesion guides the myriad of cell
behaviors that generate functional muscle tissue.
Fn is the driving force for somite boundary formation
Multiple ECM proteins and their transmembrane receptors are
expressed during segmentation and become concentrated at
somite boundaries, raising the question of which of these proteins
guide somite boundary formation. Transmembrane receptors
expressed in muscle include the DGC, Integrin alpha7, Integrin
alpha6, Integrin alpha5, and Integrin alphaV (Bajanca et al., 2004;
Lunardi and Dente, 2002; Moreau et al., 2003; Parsons et al., 2002;
Schoﬁeld et al., 1995; Song et al., 1992; Bajanca et al., 2006; Julich
et al., 2005). ECM proteins include Fn, laminin, Perlecan, and
Vitronectin (Crawford et al., 2003; Henry et al., 2001; Zoeller et al.,
2008; Handler et al., 1997; Gullberg et al., 1995). Within the last
decade, it has become clear that adhesion to Fn mediates somite
boundary formation in mouse, chick, Xenopus, and zebraﬁsh.
Fn null mouse embryos have a truncated anterior–posterior
axis, blood vessel defects, neither notochord nor somites form
(George et al., 1993; Georges-Labouesse et al., 1996), and while the
paraxial mesoderm is speciﬁed there is a complete failure of
somite condensation (Georges-Labouesse et al., 1996). Similar
results are observed in mice where the Integrin binding motif in
Fn is mutated (Girós et al., 2011). Fn is also required for segmenta-
tion in zebraﬁsh: Fn-deﬁcient zebraﬁsh display dramatic disrup-
tion of somitogenesis and cardiac development (Julich et al., 2005;
Koshida et al., 2005; Trinh and Stainier, 2004). Time-lapse analyses
have shown that ectodermal Fn plays fundamental roles in somite
epithelialization during chick development (Martins et al., 2009;
Rifes et al., 2007). Finally, Integrin alpha5 is necessary for somite
boundary formation in Xenopus (Kragtorp and Miller, 2007). Taken
together, these data indicate that adhesion to Fn plays an impor-
tant role in morphogenesis of somites, but do not elucidate the
underlying molecular mechanisms.
Fn assembly at somite boundaries is triggered by inside-out Integrin
signaling
One major question is how Fn is assembled at the somite
boundary. Cells bind Fn through speciﬁc Integrin receptor proteins.
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Thus, it is necessary to determine which Integrin receptors are
required for somite formation, and how Fn assembly is controlled
in space and time. Progress in answering these questions was
recently made by the Holley lab using the advantages of the
zebraﬁsh system (Fig. 3). Using high resolution time-lapse micro-
scopy and bimolecular ﬂuorescence complementation, Julich et al.
(2009) observed that Integrin alpha5 clustered in the presomitic
mesoderm prior to Fn polymerization. Integrin alpha5 and Integrin
beta1 form heterodimers that clustered along nascent somite
boundaries. They hypothesized that Integrin activation (inside-
out signaling) might play a role in regulating Fn polymerization. A
key result in support of this hypothesis was that a variant of
Integrin alpha5, which was unable to bind Fn, was capable of
binding Integrin beta1 and undergoing initial clustering at somite
boundaries. However, in the absence of the ability to bind Fn,
Integrin clustering was not maintained and Fn was not polymer-
ized. One aspect of ECM polymerization that is not as readily
understood, whether in somite boundaries or in other tissues, is
how “available” the matrix is for assembly. Julich et al. (2009)
investigated how available the ECM at somite boundaries was for
assembly using genetic mosaic analysis. Donor cells that lacked Fn
but expressed Integrin alpha5 were transplanted into host
embryos that lacked Integrin alpha5 but expressed Fn. Borders of
Fn matrix formed around the donor cells. This indicates that Fn in
the host was readily available to be polymerized by Integrin
alpha5 inside-out signaling in donor cells.
These experiments addressed some of the questions regarding
somite boundary formation in vivo, but did not answer how
Integrin alpha5 inside-out activation occurs or why Integrin
alpha5 only polymerizes Fn at somite boundaries. Although it
was known that the Eph/Ephrin family of cell surface molecules is
required for somite formation (Durbin et al., 1998), how Eph/
Ephrin signaling integrates with Integrin signaling during seg-
mentation was unclear. Elegant experiments showed that reverse
signaling through Ephrin receptors plays a major role in spatial
regulation of Integrin activation (Julich et al., 2009). Additional
experiments showed that a GTPase, Rap1b, acts downstream of
Ephrin reverse signaling and contributes to Integrin inside-out
activation and maintenance of Fn polymerization at somite
boundaries (Lackner et al., 2013). Taken together, these studies
clearly show that Integrin alpha5beta1 is a signiﬁcant receptor for
Fn matrix assembly at somite boundaries (Integrin alphaV also
plays a role and is partially redundant with Integrin alpha5 (Dray
et al., 2013; Yang et al., 1999)), Integrin alpha5 activation and
clustering is the key prerequisite for Fn polymerization, and that
Fn assembly by Integrin receptors involves Rap1b and is spatially
regulated to somite boundaries by Eph/Ephrin signaling (Fig. 3).
Roles for Fn in adaptation when initial somite formation is disrupted
Although somite formation per se is not necessary for muscle
speciﬁcation, segmentation is critical for organized muscle devel-
opment because segment boundaries halt elongating muscle ﬁbers
and therefore pattern muscle ﬁber length (Henry et al., 2005).
Remarkably, some zebraﬁsh with mutations that disrupt somite
formation are viable and survive to adulthood (van Eeden et al.,
1996). These ﬁsh are viable because segmentation partially
recovers and patterns the imperfect formation of segmental
elements such as vertebrae and skeletal muscle. What are the
cellular and molecular adaptations that allow this recovery of
segmentation? How does muscle properly organize in the absence
of somite boundary formation? One clue, as mentioned above, is
that slow-twitch ﬁbers in zebraﬁsh are speciﬁed medially and
migrate laterally. Slow-twitch ﬁbers elongate to irregular lengths
in the absence of somite formation but still migrate through the
presumptive fast-twitch muscle domain. As the length of fast-
twitch ﬁbers correlates with slow-twitch ﬁbers in segmentation
mutants, it was hypothesized that slow-twitch ﬁbers would be
emotoyM esuoM/kcihC emotoyM hsifarbeZ 
Dermomyotome
External Cell Layer
Scxa expressing
tendon 
progenitors 
Sclerotome
Sclerotome
Syndetome
Laminin
Fn
LamininFn
Interstitial
matrix
Muscle
pioneers
Fast-twitch fibers
Slow-twitch fibers
Fig. 2. Structure of the zebraﬁsh and amniote myotomes. (A) Top Panel – Muscle is the major constituent of the zebraﬁsh myotome. Tendon progenitors and sclerotome are
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twitch ﬁbers. (B) Top Panel – Structure of the amniote myotome. The epithelial dermomyotome contains muscle progenitor cells that will sustain growth and will also give
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the sclerotome from the myotome. Fn is primarily concentrated at myotome boundaries.
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necessary for segmental recovery. Indeed, treatment of segmenta-
tion mutants with cyclopamine, to inhibit slow-twitch muscle
speciﬁcation via disrupting Hedgehog (Hh) signaling, obliterated
segmental recovery (Henry et al., 2005). Therefore, slow-twitch
ﬁbers or some other Hh-dependent event instruct the recovery of
segmentation in segmentation mutants, but the molecular
mechanisms are not known. What is known is that Fn plays a
fundamentally critical role in this recovery because in the absence
of Fn, fast-twitch ﬁbers are not patterned by the migrating slow-
twitch ﬁbers and they are signiﬁcantly less organized (Snow et al.,
2008b). Thus, as has been hypothesized in amniotes (Bajanca et al.,
2004), Fn plays a major role in limiting/guiding muscle patterning.
These data show that Fn plays a signiﬁcant role in cellular
adaptation to generate MTJs in the absence of initial segmentation.
Cell adhesion to the ECM mediates vertebrate muscle
morphogenesis
Muscle morphogenesis begins after segmentation. During
muscle development, initial cell movements result in the forma-
tion of the primary myotome and a population of self-renewing
muscle precursor cells (Siegel et al., 2013; Scaal and Wiegreffe,
2006). Adhesion to the ECM plays an important role in regulating
both muscle speciﬁcation and morphogenesis. Musculoskeletal
differentiation then involves multiple morphogenetic processes
that require adhesion to the ECM. In brief, initially short muscle
precursor cells will elongate, attach to the ECM (Gros et al., 2004;
Snow et al., 2008a), fuse to generate multinucleate myotubes
(Sieiro-Mosti et al., 2014), and contractile myoﬁbrils will be
assembled (Sanger et al., 2009) The BM that surrounds muscle
cells will be secreted and assembled, as will the BM at the MTJ. In
this next section, we will describe the large-scale cell movements
that generate the myotome in chick, mouse, and zebraﬁsh to
provide a framework for later discussion of how cell adhesion to
the ECM regulates multiple steps of muscle morphogenesis.
Myotome morphogenesis: a paradigm for impacts of ECM on cellular
morphogenesis and differentiation
The dermomyotome in chick and mouse contains multipotent
progenitor cells that proliferate and express Pax3 and Pax7 (Ben-
Yair et al., 2003; Buckingham and Relaix, 2007). Adhesion to
laminin in the ECM via Integrin alpha6beta1 is critical to prevent
precocious differentiation in the dermomyotome (Bajanca et al.,
2006). Presumptive muscle cells then translocate into the myo-
tome and begin to differentiate (Buckingham et al., 2003). Time-
lapse studies in chick embryos have elucidated the spatial regula-
tion of entry into the myotome (Gros et al., 2005). The ﬁrst
myocytes translocate from the dorsomedial lip of the dermomyo-
tome into the presumptive myotome. These cells then elongate
bidirectionally to span the anterior–posterior length of the somite.
Next, cells from the caudal border of the dermomyotome, followed
by cells from the rostral border, translocate to the nascent
myotome and begin to form elongated muscle cells. Finally, cells
from the ventral lateral lip of the dermomyotome contribute to the
myotome. The central region of the dermomyotome will give rise
to satellite cells and muscle progenitor cells that contribute to
muscle growth (Gros et al., 2005). This process results in the
formation of the primary myotome, which is comprised of post-
mitotic, mononucleate muscle cells.
In zebraﬁsh, the functional equivalent of the dermomyotome
(the ECL) is derived from anterior border cells (the cells on the
anterior border of the somite) that also express Pax3 and Pax7
(Groves et al., 2005; Devoto et al., 2006; Siegel et al., 2013). These
progenitor cells migrate laterally soon after somite boundary
formation to form an extremely thin layer of cells that covers
the myotome. An additional difference in myotome structure
between amniotes and zebraﬁsh is that slow-twitch and fast-
twitch muscle ﬁbers are distinguished much earlier in zebraﬁsh
and are spatially segregated in the zebraﬁsh myotome (Devoto
et al., 1996). Slow-twitch muscle progenitors are initially the most
medial muscle cells, but shortly after somite formation they
undergo a dramatic lateral migration through the presumptive
fast-twitch muscle domain to become the most superﬁcial layer of
muscle (Devoto et al., 1996). Slow-twitch ﬁber migration is
necessary and sufﬁcient to trigger elongation of the fast-twitch
ﬁbers (Henry and Amacher, 2004). The terminal ends of muscle
ﬁbers attach to somite boundaries, which then become myotome
boundaries and give rise to the MTJ.
The spatial segregation of fast- and slow-twitch muscle ﬁbers
in zebraﬁsh has facilitated understanding of ﬁber type speciﬁca-
tion. In zebraﬁsh, superﬁcial slow-twitch ﬁbers (SSFs), muscle
pioneer ﬁbers (MPs), and medial fast-twitch ﬁbers (MFFs) are
speciﬁed early in muscle development by Hh, BMP, and FGF
signaling (Du et al., 1997; Hirsinger et al., 2004; Nguyen-Chi
et al., 2012; Wolff et al., 2003). Engrailed expression in response
to high levels of Hh ligand secreted from the notochord normally
patterns MPs and MFFs. Recent experiments have shown that the
ECM functions upstream of ﬁber speciﬁcation. In the context of
muscle ﬁber speciﬁcation in zebraﬁsh, it was shown that laminin
is required for normal engrailed expression. Engrailed is greatly
reduced in lamc1 mutant embryos. Surprisingly, this phenotype
was not due to a lack of Hh signal transduction, but rather ectopic
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Fig. 3. Ephrin reverse signaling and Rap1b contribute to Integrin clustering/activation, which results in Fn polymerization at the nascent somite boundary. Fn (green) is
available for polymerization in the presomitic mesoderm but is not organized. Signaling through Ephrin receptors results in Integrin clustering (and presumably activation).
Next, inside-out Integrin signaling potentiates Fn polymerization, leading to formation of intersomitic clefts. The alignment and enlargement of these clefts, along with
epithelialization of the border cells, results in the formation of stable somite boundaries.
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activation of BMP signaling which, in this context, antagonizes Hh
signaling (Maurya et al., 2011). BMP ligand availability in the
zebraﬁsh muscle ECM is regulated by laminins via HSPGs (Dolez
et al., 2011). The addition or removal of sulfate groups on the
glycosaminoglycan side chains of HSPGs appears to impact the
ability of HSPGs to regulate extracellular signaling ligands and
muscle cell fate in zebraﬁsh. Similar to lamc1 mutants, zebraﬁsh
deﬁcient for Sulf1 (an enzyme that removes sulfate groups from
HSPG side chains) have reduced muscle engrailed expression,
normal Hh signal transduction, and increased BMP signaling
(Meyers et al., 2013). An earlier report found that zebraﬁsh
deﬁcient for hs6st, an enzyme that adds sulfate groups to HSPG
glycosaminoglycans, have an expanded domain of engrailed
expression in muscle despite normal Hh signaling (Bink et al.,
2003). While levels of BMP signaling were not investigated in
these embryos, one can hypothesize that BMP signaling would be
reduced. Altogether, these data show that interactions between
different ECM proteins and the post-translational modiﬁcation of
ECM components regulate cell signaling and muscle cell fate.
Cell biology of muscle fusion
One key process involved in generating multinucleate muscle
ﬁbers is muscle fusion. Studies in Drosophila have identiﬁed a
number of proteins required for myoblast fusion (Beckett and
Baylies, 2007; Chen and Olson, 2004). The fact that the primary
myotome in amniotes and zebraﬁsh is mononucleate (Gros et al.,
2004; Waterman, 1969) indicates that myoblast fusion does not
mediate the earliest stages of muscle morphogenesis in verte-
brates. This fact was conﬁrmed with live imaging studies in both
chick and zebraﬁsh (Gros et al., 2004; Snow et al., 2008a).
Although use of the Drosophila system has provided tremendous
insight into fusion mechanisms during ﬂy muscle development, it
is generally unclear whether these mechanisms are conserved in
vertebrates (Powell and Wright, 2012). In addition, the cell biology
underlying fusion (i.e. what populations of muscle cells fuse) is not
well understood. Two excellent studies (Sieiro-Mosti et al., 2014;
Powell and Wright, 2011) have provided some insight into cellular
and molecular aspects of vertebrate muscle cell fusion.
Identifying the cellular mechanisms underlying muscle fusion
is critical for understanding muscle development and regenera-
tion. Electroporation of ﬂuorescent proteins into different regions
of the amniote dermomyotome – the dorsal medial lip, dorsal
dermomyotome, or anterior/posterior borders of the dermomyo-
tome – allowed quantiﬁcation of fusion with regards to muscle cell
length and volume. This study showed cells in the primary
myotome typically fuse with themselves and resident progenitors
generally fuse with each other, but that the primary myotome cells
do not fuse with resident muscle progenitors in trunk muscle.
Limb muscle fusion differed from trunk muscle fusion in two ways.
In limb muscle, addition of myonuclei correlated with an increase
in muscle cell length. In contrast, trunk muscle cells remained the
length of one segment regardless of the number of nuclei. The
speed of fusion was also different in the two populations, with
limb muscles fusing dramatically faster (Sieiro-Mosti et al., 2014).
Thus, this study provides a conceptual framework for future
molecular studies.
Another excellent study identiﬁed, for the ﬁrst time, mutants
with speciﬁc defects in muscle fusion. Given that the initial
myotome contains mononucleate muscle cells, any putative fusion
mutant would be expected to have long muscle cells that are
mononucleate. In other words, fusion would not be predicted to be
required for muscle elongation. What was not knownwas whether
fusion was required for sarcomerogenesis or what molecules
mediate fusion. Powell and Wright identiﬁed two vertebrate
speciﬁc cell surface receptors required for fast-twitch muscle
fusion in zebraﬁsh: Jamb and Jamc (Powell and Wright, 2011).
These proteins are deuterostome speciﬁc immunoglobulin super-
family cell surface proteins with two extracellular immunoglobu-
lin superfamily domains, a transmembrane domain, and a short
cytoplasmic domain (Ebnet et al., 2004). Although fast-twitch
ﬁbers are speciﬁed and appear morphologically normal in jamb
or jamc mutants, fusion does not occur (Fig. 4). Biochemical and
genetic mosaic analyses demonstrated that Jamb and Jamc interact
and this interaction is required for fusion. Although mechanisms
downstream of Jamb and Jamc were not identiﬁed, this landmark
study has set the bar for rigorous analysis of molecules required
speciﬁcally for vertebrate muscle fusion and not other aspects of
muscle morphogenesis. It will be interesting in the future to
determine if these genes are also required for muscle fusion in
mammals.
Muscle cell elongation requires adhesion to laminin
The above studies elucidated cell movements that generate the
myotome but not how short muscle precursor cells elongate to the
segment boundaries. Determining the cellular basis of primary
myotome morphogenesis is necessary for a more precise under-
standing of the questions that need to be resolved at a molecular
level. Live imaging studies in the chick and zebraﬁsh models have
highlighted a remarkable degree of conservation of the cellular
mechanisms underlying initial ﬁber elongation (Gros et al., 2004;
Snow et al., 2008a; Gros et al., 2009). These complementary studies
have identiﬁed discrete morphogenetic steps mediating muscle ﬁber
morphogenesis and thus provide an excellent framework for mole-
cular analyses of muscle morphogenesis.
Initially short precursor cells extend short ﬁlopodia-like protru-
sions in all directions in both model systems. Once cells begin to
elongate they do so in a directed fashion, with protrusions extended
in the direction of elongation (Fig. 4) (Gros et al., 2004; Snow et al.,
2008a; Gros et al., 2009). One interpretation of the fact that short
muscle cells extend protrusions in all directions is that these cells
are “searching” for the appropriate direction in which to elongate.
Thus some questions are: what are the molecules that guide
oriented elongation? What are the signaling pathways that mediate
the switch to oriented elongation? How do elongating myocytes
gain traction for elongation?
The morphology of elongating muscle cells is remarkably
similar to that of migrating cells. Cell migration requires cycles
of membrane extension, adhesion to the ECM, cell body transloca-
tion, and detachment from the ECM (Lauffenburger and Horwitz,
1996; Mitchison and Cramer, 1996; Murray and Oster, 1984). The
difference between elongating muscle cells and migrating cells is
that the “tail” of elongating muscle cells does not detach and
retract back to the cell body. Thus, it is quite reasonable to
hypothesize that cell adhesion to the ECM is required for traction
forces necessary for muscle cell elongation, but which ECM
proteins are required? Given that Fn is renowned for its role in
cell migration, it is somewhat surprising that Fn is not required for
muscle cell elongation in zebraﬁsh (Snow et al., 2008b). In
contrast, adhesion to laminin is necessary for muscle cell elonga-
tion in both mouse and zebraﬁsh. Muscle cell elongation is
disrupted in mouse explants incubated with an antibody against
the laminin receptor Integrin alpha6beta1 (Bajanca et al., 2006).
Fast-twitch muscle cell elongation is delayed in zebraﬁsh lamb1 or
lamc1 mutant embryos (Snow et al., 2008a). These data clearly
indicate that adhesion to laminin is necessary for muscle ﬁber
elongation in zebraﬁsh and mouse but the mechanisms are not
known. Are cells unable to exhibit traction to elongate initially?
Are the tips of elongating cells unable to stably adhere to the
matrix and thus retract? What occurs downstream
of laminin binding to promote muscle cell elongation? These
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questions need to be answered in order to obtain a complete
understanding of mechanisms guiding muscle ﬁber morpho-
genesis.
Observations of older embryos showed that although adhe-
sion to laminin is required for efﬁcient elongation of muscle
precursor cells, muscle cells eventually recover and elongate in
zebraﬁsh lamb1 or lamc1 mutant embryos (Snow et al., 2008a) (it
is not known if elongation recovers in the mouse). This recovery
demonstrates how critical the dimension of time is when
collecting and interpreting results in developing embryos, and
implies the existence of a latent compensatory mechanism for
fast-twitch muscle morphogenesis. What is this secondary
mechanism? Hh signaling is known to be involved because fast-
twitch muscle cells in lamc1 mutant embryos incubated in
cyclopamine do not elongate, even after several days of devel-
opment (Peterson and Henry, 2010). Hh signaling is known to act
both directly and indirectly in the zebraﬁsh myotome (Feng et al.,
2006; Henry and Amacher, 2004). In this context, it was shown
that Hh signaling acts indirectly through the speciﬁcation of
slow-twitch ﬁbers (Peterson and Henry, 2010). In summary,
although laminin is required for efﬁcient elongation of fast-
twitch muscle cells, elongation recovers in laminin mutant
embryos. The recovery mechanism involves the cell population
that triggers fast-twitch muscle cell elongation initially – the
slow-twitch muscle ﬁbers. Clearly, there is much to be learned
but understanding these latent “back-up” mechanisms of
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Fig. 4. Cartoon of muscle morphogenesis in chick and zebraﬁsh embryos. (A) Developing zebraﬁsh myotome. Slow-twitch ﬁbers (gray) have migrated partway through the
fast-twitch domain. Fast-twitch muscle cells (dark blue) medial to the slow-twitch ﬁbers are long. Fast-twitch cells (medium blue) directly intermingled with migrating
slow-twitch ﬁbers are elongating. Lateral to the slow-twitch ﬁbers are short muscle precursor cells (light blue) extending protrusions in all directions and the external cell
layer (red). (B) Developing chick myotome. Note that short myoblasts extend protrusions in all directions, but once elongation has begun protrusions are extended only in the
direction of elongation. (C) More detailed view of the initial stages of muscle ﬁber morphogenesis that are similar in amniotes and zebraﬁsh. Short precursor cells extend
protrusions in all directions. Once cells begin elongating, they do so in an oriented fashion. Adhesion to laminin is required for oriented myocyte elongation in both species,
WNT11 is required for oriented elongation in chick. Boundary capture involves the cessation of muscle cell elongation and regulates muscle cell length. Fn regulates
myotomal muscle cell length in both zebraﬁsh and chick, and laminin has been shown to play a role in boundary capture in the zebraﬁsh system. (D) Genes required for
muscle fusion in zebraﬁsh. To date, the only proteins whose disruption leads to a speciﬁc defect in fusion (with all other aspects of muscle morphogenesis appearing normal)
are jamb and jamc. Once fusion has occurred, myoﬁbrillogenesis, growth, innervation, and homeostasis all require adhesion to the ECM.
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morphogenesis could be important to provide insight into cel-
lular adaptation, the evolution of development, and potential
alternative therapeutic approaches for muscle diseases.
Some inroads have been made into understanding how muscle
cells elongate in an oriented fashion. The myotome is highly
organized because elongated myotubes are aligned with each
other and oriented in the anterior–posterior axis. How is this
order controlled? What are the cues that guide oriented elonga-
tion of short muscle precursor cells? Adhesion to laminin via
Integrin alpha6beta1 is necessary for ﬁber organization in the
mouse and zebraﬁsh (Bajanca et al., 2006; Goody et al., 2012) but
the mechanism of how laminin contributes to myotome order is
not clear. Recent data using head and neck squamous carcinoma
cells shows that cellular traction forces guide invadopodia and
ECM degradation (Jerrell and Parekh, 2014). Thus, it is possible
that efﬁcient elongation, and the resulting deformations in the
ECM, guide muscle cell elongation and myotome organization. An
excellent study showed that WNT11 acts as a directional cue to
guide muscle cell elongation in chick embryos: WNT11 is both
necessary and sufﬁcient for oriented elongation (Gros et al., 2009)
(Fig. 4). The mechanism of WNT11 action is not known and it is not
clear whether WNT11 and laminin adhesion pathways interact.
The only known interaction between WNT11 and laminin is that
WNT11 transcription is signiﬁcantly downregulated in kidneys of
lamc1 mutant embryos (Yang et al., 2011). It will be quite inter-
esting in the future to clarify mechanisms of oriented elongation,
whether these mechanisms are conserved, and whether laminin
and WNT11 interact in oriented muscle cell elongation.
Boundary capture and regulation of ﬁber length: roles for Fn and
laminin
A critical aspect of muscle morphogenesis is the cessation of
muscle ﬁber elongation. The mechanisms that instruct elongating
muscle cells to stop elongating are fundamental for normal muscle
morphogenesis. Axial skeletal muscle ﬁbers stop elongating when
they hit the anterior and posterior segment boundaries (Henry
et al., 2005). This process is called boundary capture. Boundary
capture is mediated by laminin signaling in the zebraﬁsh model
(Snow et al., 2008a). Data from both zebraﬁsh and mouse models
suggest that Fn may play a role in ensuring proper length of axial
skeletal muscle ﬁbers (Snow et al., 2008b; Bajanca et al., 2004).
Here, we will brieﬂy discuss evidence for Fn in muscle cell–ECM
interactions at segment boundaries. Next, we will discuss roles for
laminin polymerization in boundary capture in zebraﬁsh and
myotome organization in mouse.
In mouse, elongating myocytes express the Fn receptors Integ-
rin alpha4beta1 and alpha5beta1. These myocytes appear to attach
to the intersegmental ECM that is rich in Fn (Bajanca et al., 2004).
These data suggest that Fn plays a role in boundary capture.
Unfortunately, disrupted mesoderm development in Fn null mice
precludes analysis of how Fn contributes to muscle organization
(Georges-Labouesse et al., 1996). Data from zebraﬁsh using mor-
pholinos to reduce but not abolish Fn also suggest that Fn is critical
to reinforce segment boundaries. In embryos with reduced Fn,
fast-twitch ﬁbers are not patterned by migrating slow-twitch
ﬁbers and they are signiﬁcantly less organized (Snow et al.,
2008b). Exciting recent data suggest that a tetraspanin acts
upstream of Integrin alpha5 in regulating ﬁber length. The
transmembrane protein Tm4sf5 is best known as a promoter of
EMT via enhancing activation of the cell–ECM adhesion protein
focal adhesion kinase (FAK) (Jung et al., 2012). Tm4sf5 is expressed
during muscle development in zebraﬁsh (Choi et al., 2014). Tm4sf5
morphants display abnormal segment boundaries in addition to
fewer and disorganized muscle ﬁbers. Injection of Integrin alpha5
rescued embryos deﬁcient for Tm4sf5, indicating that this protein
functions upstream of Integrin alpha5 (Choi et al., 2014). One
critical function of Fn is to regulate deposition of type I and III
collagens in the ECM (Sottile and Hocking, 2002; Velling et al.,
2002). Interestingly, it has recently been shown that the ability of
Fn to bind to collagen is critical for Fn-stimulated cell migration
during wound healing (Sottile et al., 2007). Although this study
was in vitro, the dynamic interaction between Fn-dependent
collagen deposition and Fn-dependent cell migration highlights
the need for integration of multiple ECM components when
studying developmental processes. Taken together, these studies
indicate that Fn plays a conserved role in limiting/guiding muscle
patterning; although Fn may act directly in mammals and indir-
ectly through slow-twitch ﬁbers and/or collagen deposition in
zebraﬁsh.
Laminin also plays a conserved role in regulating myotome
organization. In mice, laminin is thought to act as a barrier that
keeps myogenic cells inside the myotome. When laminin poly-
merization is compromised, myocytes disperse to the sclerotome
region (Bajanca et al., 2006). In lamb1 or lamc1 mutant zebraﬁsh,
some fast-twitch muscle cells do not stop elongating at segment
boundaries and instead extend into the adjacent myotome (Snow
et al., 2008a). A dense network of polymerized laminin could
function as a physical barrier or, alternatively, laminin binding may
result in cell autonomous signaling that retains cells within their
myotomes. To discriminate between these possibilities, genetic
mosaic experiments were performed where wild-type muscle
cells were transplanted into laminin gamma1-deﬁcient embryos.
The rationale was that wild-type cells might be able to secrete
small amounts of laminin that would not act as a physical barrier
(too little laminin), but could play a role in signaling that would
facilitate boundary capture. Indeed, transplanted cells were sig-
niﬁcantly less likely to cross MTJs, indicating that boundary
capture is a cell autonomous process (Snow et al., 2008a). Thus,
it is likely that intracellular signaling downstream of laminin
binding plays a major role in boundary capture and therefore
muscle shape. In the future, it will be important to identify events
downstream of laminin binding.
Laminin polymerization
One major focus of recent research, given the importance of
laminin in muscle development and homeostasis, has been to under-
stand how laminin polymerization and BM assembly are mediated
in vivo. Translated laminin gene products (one alpha, one beta, and
one gamma) assemble into cross-shaped laminin proteins with the
alpha subunit constituting the long arm of the cross and the beta and
gamma subunits forming the short arms of the cross. The short arms
of laminin bind to each other, resulting in self-assembly (Colognato
and Yurchenco, 2000; LeBleu et al., 2007). Assembled laminin proteins
can then go on to polymerize with other laminin proteins and other
ECM molecules to form specialized BMs. Roles for laminin-111 in
triggering BM assembly in mouse muscle were shown by providing
exogenous laminin-111 to Shh / ;Gli3 / embryos that do not
express laminin-111. These elegant experiments clearly demonstrated
that laminin-111 is necessary and sufﬁcient to initiate myotomal BM
assembly (Anderson et al., 2009). In addition to self-assembly, laminin
polymerization can be guided by cellular receptors for laminin that
nucleate and organize laminin polymerization (Colognato
and Yurchenco, 2000; LeBleu et al., 2007; Thorsteinsdóttir, 1992).
Important questions that remain are which laminin recep-
tors play roles in laminin polymerization and what mechanisms are
involved.
The location of the myotomal BM differs in amniotes and
teleosts. Whereas the somite boundary gives rise to the MTJ in
teleosts, the myotomal BM in amniotes is assembled de novo
(Anderson et al., 2009, 2007; Deries et al., 2012). Despite these
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differences, laminin receptors appear to potentiate polymerization in
amniotes and teleosts. Correlative data implicate the laminin recep-
tor Dystroglycan (Dag1) because Dag1 expression increases when
laminin polymerizes in both mouse and zebraﬁsh (Anderson et al.,
2007; Snow and Henry, 2009). In addition, there are functional data
showing conserved roles for the laminin receptor Integrin alpha6-
beta1 in laminin polymerization. Blocking Integrin alpha6beta1
interactions with laminin results in a patchy BM in mouse myotomes
(Bajanca et al., 2006). Laminin polymerization at the MTJ is also less
organized in zebraﬁsh deﬁcient for Integrin alpha6 or the Integrin
beta1 binding protein Nrk2b (Goody et al., 2012; 2010). While
Integrin alpha6beta1 appears to be the main laminin receptor
mediating MTJ BM polymerization, Integrin alpha7 and Dag1 were
also found to play minor roles in zebraﬁsh MTJ morphogenesis
(Goody et al., 2012). Taken together, these data indicate that multiple
laminin receptor complexes are required for normal laminin poly-
merization at the MTJ during muscle development.
In zebraﬁsh, failure to polymerize laminin at the MTJ can result in
abnormally long muscle ﬁbers that span the length of multiple
muscle segments (referred to as boundary crossings). Similar to
inside-out signaling through Integrin alpha5beta1 promoting Fn
matrix polymerization during segmentation, inside-out signaling
through Integrin alpha6beta1 appears to be one way of potentiating
laminin polymerization at the MTJ BM and limiting muscle ﬁber
length. Overexpression of the intracellular Integrin binding protein
Paxillin rescued boundary crossings in Nrk2b-deﬁcient zebraﬁsh and
laminin polymerization in Dag1 deﬁcient zebraﬁsh, but could not
rescue these muscle phenotypes without the presence of Integrin
alpha6 (Goody et al., 2012; 2010). Boundary crossings were also
observed in zebraﬁsh deﬁcient for the extracellular BM glycoprotein
Periostin (Kudo et al., 2004). It is not known exactly how Periostin
limits muscle ﬁber length in zebraﬁsh, but neither segmentation nor
boundary capture phenotypes were observed suggesting that Peri-
ostin likely limits ﬁber length by contributing to MTJ development.
ECM molecules are required to maintain MTJ integrity during muscle
tissue stress
A ﬁnal step of muscle morphogenesis that must be continued
throughout life is maintenance of MTJ structure despite repeated
cycles of contraction and relaxation, injury and repair. Multiple genes
encoding ECMmolecules (lama2, tsp4b, and col22a1) have been shown
to be necessary for MTJ homeostasis in zebraﬁsh. Not surprisingly,
these genes are expressed during later stages of muscle morphogen-
esis and their expression becomes restricted to the MTJ (Charvet et al.,
2013; Hall et al., 2007; Subramanian and Schilling, 2014; Sztal et al.,
2012). Zebraﬁsh mutants or morphants deﬁcient for laminin alpha2,
thrombospondin 4b or collagen 22a1 proteins have mild muscle
defects; however, when muscle contraction is stimulated (either
mechanically or electrically), the muscle phenotype becomes severe
with many muscle ﬁbers retracting from the MTJ (Charvet et al., 2013;
Hall et al., 2007; Subramanian and Schilling, 2014). Unlike the case in
mouse and zebraﬁsh models with dystrophin mutations, the muscle
ﬁbers did not rupture, they were found to retract from the MTJ intact
(Charvet et al., 2013; Gupta et al., 2012; Hall et al., 2007; Subramanian
and Schilling, 2014). Therefore, rather than stabilizing the sarcolemma,
these ECM proteins play a role in muscle health by maintaining
integrity of muscle cell adhesion to the ECM at the MTJ.
The extracellular matrix, cellular adaptation, and muscle
disease
We have focused on roles for ECM molecules in early muscle
morphogenesis. Changes in the muscle ECM also play major roles
– both positive and negative – later in life during muscle aging and
disease. We will now address our second theme by discussing how
muscle cell–ECM interactions regulate cellular adaptive responses
in homeostasis and disease. One well-known (and frequently
sought after) example of cellular adaptation in normal physiology
is hypertrophy of skeletal muscle cells in response to weight
bearing exercise (McDonagh and Davies, 1984). A far less desired,
pathological cellular adaptation is resistance of cancer cells to
therapy (reviewed in Cojoc et al., 2014); such as cancer cells using
adaptive evasion to exit mitosis without proper cell division in
response to drugs that induce mitotic arrest (Díaz-Martínez et al.,
2014). Cellular adaptations are becoming a focus of biomedical
research because, if better understood, innate cellular adaptation
mechanisms could be augmented or inhibited for therapeutic
beneﬁt. As musculoskeletal health plays a major role in system
health (e.g. posture, strength, mobility, metabolism) and pioneer-
ing work on cellular adaptation was conducted in skeletal muscle
tissue, we believe muscle is a prime fertile ground for under-
standing the contribution of cellular adaptation to system health
in normal and disease states. In our opinion, whether it be for
improving physique or conquering cancer, understanding the
mechanisms underlying cellular adaptation is one of the next
major frontiers in systems biology. In the sections to follow, we
will review roles for three ECM glycoproteins in either physiolo-
gically beneﬁcial or deleterious skeletal muscle adaptations to
disease (Table 1).
Adhesion to laminin plays a major role in cellular adaptation during
muscle disease
In skeletal muscle, adhesion of muscle ﬁbers to the BM is
necessary for muscle development, regeneration, and homeosta-
sis. This requirement for muscle–BM adhesion is highlighted by
the genetic basis for many muscular dystrophies; these are
progressive, debilitating diseases without cures. Mutations in
genes encoding muscle ECM components or proteins in ECM
receptor complexes can lead to muscular dystrophies. For exam-
ple, mutations in the human lama2 gene result in Merosin-
deﬁcient congenital muscular dystrophy (MDC1A) (Helbling-
Leclerc et al., 1995). Perhaps the most well known of the dystro-
phies is Duchenne muscular dystrophy (DMD), caused by muta-
tions in the dystrophin gene, resulting in loss of muscle cell/ECM
connection (Hoffman et al., 1987). Because disruption of muscle
cell adhesion to the matrix can lead to muscle diseases, a major
focus of current research is to identify approaches that enhance
adhesion of muscle ﬁbers to their ECM.
As mentioned above, there are multiple receptor complexes for
laminin (Integrin alpha6beta1, Integrin alpha7beta1, the DGC, and
the UGC). Generation of double mutants and overexpression
studies have shown that although these receptor complexes have
unique roles; they exhibit some functional overlap and can act
synergistically. It is possible that understanding the intrinsic
compensatory functions of these laminin receptor complexes
would allow development of therapeutics that improve muscle
pathology. Compensatory adhesion approaches towards develop-
ing therapies to improve muscle structure and function have
included: (1) increasing the expression/functionality of an uncom-
promised adhesion complex (e.g. the UGC), and (2) augmenting
the BM. Readers interested in other approaches toward therapeu-
tics that are outside the scope of this review (exon skipping, stem
cell therapies) are referred to excellent recent reviews on alternate
therapeutic avenues (Aartsma-Rus, 2012; Meregalli et al., 2013).
Here, we will discuss exciting data regarding the remarkable
ability of muscle cells to adapt when one mode of cell adhesion
to laminin is disrupted, and the potential for this intrinsic adapta-
tion to be exploited for therapeutic purposes.
M.F. Goody et al. / Developmental Biology 401 (2015) 75–9184
In some mouse models for muscular dystrophies, there are
intrinsic adaptive cellular responses that upregulate an uncom-
promised receptor complex. This upregulation can lead to an
improved BM. This was ﬁrst discovered when it was noticed that
the mdx mouse model of DMD had reduced muscle pathology
compared to boys with DMD (Tanabe et al., 1986). It was hypothe-
sized that upregulation of the UGC and Integrin receptors could be
compensating for the disrupted DGC. Indeed, phenotypes are more
severe in mdx/Itga7 (Guo et al., 2006; Rooney et al., 2006), mdx/utr
(Deconinck et al., 1997; Grady et al., 1997), and utr/Itga7 (Welser
et al., 2009) double mutants. Critically, the background strain of
mouse on which themdxmutation was placed had a central role in
the ability of the muscle to maintain itself (Fukada et al., 2010),
with the DBA/2J strain exhibiting greatly decreased satellite cell
renewal potential. Exactly what the genetic and molecular
mechanisms of this defect are in DBA/2J compared to the original,
more adaptive C57BL/10 strain remain to be determined and may
provide key insight into the ability of muscle to compensate.
Similar results have been observed in the zebraﬁsh model. Muscle
pathology is also exacerbated in zebraﬁsh deﬁcient for Integrin
alpha7 and Dag1, Integrin-linked kinase and Dag1, or Integrin-
linked kinase and Dystrophin compared to knockdown or muta-
tion of a single gene (Goody et al., 2012; Sztal et al., 2012). These
data from two different vertebrates provide validation for the
approach of potentiating the activity of compensatory adhesion
complexes to ameliorate muscle diseases in humans. Indeed,
approaches for upregulation of the UGC and/or Integrin alpha7-
beta1 expression are being pursued. One interesting approach is
Sarcospan overexpression because Sarcospan appears to have a
pleiotropic beneﬁcial effect in dystrophic muscle by both upregu-
lating DGC/Integrin expression and membrane trafﬁcking
(Marshall and Crosbie-Watson, 2013). Similarly, upregulating
Utrophin is a promising potential therapy for DMD (Phase I clinical
trials) (Fairclough et al., 2013).
Other innovative approaches have been to consider providing
different isoforms of laminin. In MDC1A, caused by mutations in
lama2, there is a partial increase in laminin alpha4 synthesis and a
decrease in amounts of two laminin receptors, Integrin alpha7beta1
and the DGC (Bentzinger et al., 2005; Kortesmaa et al., 2000; Moll
et al., 2001; Patton et al., 1997; Ringelmann et al., 1999; Vachon
et al., 1997). Unfortunately, increased laminin alpha4 does not fully
compensate for the lack of laminin alpha2 because laminin alpha4
does not self-polymerize or bind to the DGC or Integrin alpha7beta1
with high afﬁnity (Kortesmaa et al., 2000; Talts et al., 2000). As
mentioned above, laminin-111 is the major developmental isof-
orm of laminin. Remarkably, laminin-111 protein therapy signiﬁ-
cantly improves pathology of mouse models for MDC1A, DMD, and
congenital myopathy with Integrin alpha7 deﬁciency (Rooney
et al., 2009a; 2009b; 2012). Thus, laminin-111 protein therapy may
be a viable approach, although effective delivery of laminin-111 to
muscle tissue in large mammals has not yet been demonstrated.
Striking data indicate that some dystrophic muscle cells can generate
their own ectopic BM and maintain viability. Zebraﬁsh softy mutants
are homozygous viable despite being identiﬁed as part of the
dystrophic class of mutants in one of the ﬁrst large-scale zebraﬁsh
forward genetic screens (Granato et al., 1996). The softy phenotype is
caused by a mutation in the lamb2 gene. In softy mutants, muscle
ﬁbers detach from the BM at the MTJ but their sarcolemma remains
intact. What is remarkable is that some of the ﬁbers do not detach
fully, but rather remain striated and attach to an ectopic BM. As these
ectopic ﬁber terminations are unique in the zebraﬁsh dystrophy
models, and softy mutants are unique in that they are homozygous
viable, it is hypothesized that these ectopic ﬁber terminations
function to stabilize the damaged myotome (Jacoby et al., 2009).
This could allow more robust regeneration or slow down degenera-
tion. Certainly, understanding the mechanisms underlying the recov-
ery from early and severe muscle degeneration is critical because it
may provide novel insight into therapeutic approaches.
An alternate approach is to identify small molecules that potenti-
ate muscle cell adhesion to laminin either through hypothesis-driven
testing of chemicals or large-scale chemical screening. Zebraﬁsh
models of muscular dystrophies are being used to pursue both of
these approaches. The Nrk2b pathway that mediates laminin-111
polymerization during development ameliorates muscle damage in
Integrin alpha7 or Dag1-deﬁcient zebraﬁsh (Fig. 5) (Goody et al.,
2012). Chemical screens have shown phosphodiesterase inhibitors
(Kawahara et al., 2011), upregulation of heme oxygenase 1 (Kawahara
et al., 2014), and selective serotonin reuptake inhibitors (Waugh
et al., 2014) reduce disease severity in the zebraﬁsh model of DMD.
Thus, understanding and being able to manipulate the intrinsic
cellular adaptive responses that occur in diseased muscle tissue,
whether they be between laminin receptors, ECM components, or
metabolic/hormone signaling pathways, could be of beneﬁt to the
many people with genetic or acquired muscle diseases.
Table 1
ECM related cellular adaptive responses in diseases.
Gene/gene product disrupted Cellular adaptive response demonstrated Reference
mdx/utr, mdx/itga7, or utr/itga7 double knock out mice Compensation between Dystrophin, Utrophin, and
Integrin alpha7
(Guo et al., 2006; Rooney et al., 2006;
Deconinck et al., 1997; Grady et al., 1997;
Welser et al., 2009)
Dystroglycan/Integrin alpha7, Dystroglycan/Integrin-linked
kinase, or Dystrophin/Integrin-linked kinase double
knockdown in zebraﬁsh
Compensation between Dystroglycan or Dystrophin
and Integrin alpha7 and/or Integrin linked kinase
(Goody et al., 2012; Sztal et al., 2012)
mdx mice Sarcospan overexpression sufﬁcient to increase DGC,
UGC, and Integrin alpha7beta1 sarcolemma expression
(Marshall and Crosbie-Watson, 2013)
Human DMD Increased Utrophin is beneﬁcial (Fairclough et al., 2013)
lama2 Partial compensation by increased laminin alpha4 (Kortesmaa et al., 2000; Talts et al., 2000)
lama2, mdx, or itga7 mutant mice Laminin-111 protein therapy beneﬁcial (Rooney et al., 2009a; 2009b; 2012)
lamb2 mutant zebraﬁsh Fibers form and attach to ectopic BMs (Jacoby et al., 2009)
Integrin alpha7 or Dystroglycan deﬁcient zebraﬁsh Exogenous NADþ supplementation enhances
basement membrane
(Goody et al., 2012)
dmd mutant zebraﬁsh Phosphodiesterase inhibitors, upregulation of heme
oxygenase 1, or selective serotonin reuptake inhibitors
beneﬁcial
(Kawahara et al., 2011; 2014; Waugh et al.,
2014)
itga7 mutant mice Integrin alpha5 and Fn are upregulated (Nawrotzki et al., 2003)
lama2 mutant mice Fn is upregulated (Mehuron et al., 2014)
Decorin/Biglycan double knock out mice Compensation between Decorin and Biglycan in
collagen ﬁbrillogenesis in bone and cornea
(Young et al., 2002; Zhang et al., 2009)
col4a3 mutant mice Upregulation of col4a1, col4a2, lama1, and lama5 (Abrahamson et al., 2007)
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The dark side of Fn: ﬁbrosis
Fn plays a key role in the stem cell niche during muscle
regeneration, being both necessary and sufﬁcient for satellite cell
expansion (Bentzinger et al., 2013). This role for Fn in generating a
supportive ECM microenvironment is reminiscent of how Fn
upregulation by bone marrow-derived hematopoietic progenitor
cells generates a permissive premetastatic niche and instructs
organ-speciﬁc tumor spread (Kaplan et al., 2005; 2006). However,
despite playing critical roles in muscle development and regen-
eration, Fn may also contribute to pathology in aging and diseased
muscle. Abnormal ECM deposition, including Fn deposition, is
observed in ﬁbrotic tissue in both cardiac and skeletal muscle
(Bertolotto et al., 1983; Booth et al., 2012; Li et al., 2008). Fn is
frequently assessed as a marker of ﬁbrosis and disrupted Fn has
been observed in humans with various muscular dystrophies
(Martin et al., 2014; Higashi et al., 2005; Martoni et al., 2013;
Sáenz et al., 2008). The replacement of contractile muscle tissue by
Fn-rich ﬁbrotic material leads to diminished organ function.
Fibrosis can be thought of as an aberrant wound healing
response (Mann et al., 2011). The inﬂammatory state induced in
response to an acute tissue injury activates and recruits cells (e.g.
macrophages, ﬁbroblasts) that clean up debris and synthesize new
cytoskeletal and ECM components (e.g. alpha-smooth muscle
actin, Vimentin, collagens, Fn). This phase is followed by resolution
of inﬂammation, degradation of the temporary ECM, and restora-
tion of normal cellular and tissue architecture and function.
Chronic muscle damage, in contrast, is often associated with
chronic inﬂammation that results in aberrant deposition of ECM.
While Fn can promote muscle repair, there seems to be a limited
time, place, and duration of Fn expression that is beneﬁcial in
muscle regeneration. In Itga7 mutant mice, Integrin alpha5 and Fn
remain concentrated around muscle ﬁbers and at MTJs before
muscle wasting is observed (Nawrotzki et al., 2003). In lama2
mutant mice Fn was the most upregulated of the ECM components
assayed early in disease progression (Mehuron et al., 2014). The
increase in Fn in these animal models of muscular dystrophy was
suggested to be an early marker and pathomechanism in these
diseases. It is clear that understanding how Fn expression is
dynamically regulated will be critical to promote proper muscle
repair even when damage is chronic. Proinﬂammatory cytokines
and growth factors are known to regulate Fn expression in muscle
tissue: Connective Tissue Growth Factor is sufﬁcient to increase Fn
in wild-type mouse muscle (Morales et al., 2011) and Transforming
Growth Factor-beta is sufﬁcient to increase Fn protein in cultured
muscle cells (Li et al., 2004). Proteoglycans in the ECM of skeletal
muscle likely play important roles in regulating muscle tissue
ﬁbrosis because they can bind proinﬂammatory cytokines and
growth factors and modulate their signaling (reviewed in Brandan
and Gutierrez, 2013). Fn upregulation is not only a result of the
proinﬂammatory state, but alternative splicing of Fn can itself
activate inﬂammatory signaling cascades and induce production of
proinﬂammatory cytokines (Kelsh et al., 2014). This results in a
positive feedback loop between inﬂammation and Fn expression.
Therefore, interrupting the cycle between inﬂammation-induced
Fn expression and Fn-induced inﬂammatory signaling could be a
fruitful approach to prevent the ﬁbrosis associated with muscle
diseases and aging.
Do collagens compensate for each other?
Cellular adaptations in response to disruption of many ECM
molecules remain largely unexplored; such is the case for the
collagen family of genes. Type IV collagen is expressed in BMs and
collagen 22a1 is required for MTJ homeostasis in zebraﬁsh muscle,
but it is mutations in type VI collagen genes that cause the second
most common form of congenital muscular dystrophy: Ullrich
congenital muscular dystrophy (UCMD). Mutations in type VI
collagen genes can also cause a less severe muscular dystrophy
called Bethlam myopathy. Mice with col6a1 mutations have
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Fig. 5. An organized ECM microenvironment rescues ﬁber resiliency in Dag1-deﬁcient cells (from Goody et al., 2012). Anterior left, dorsal top, side-mounted, 3 dpf embryos.
(A) Polarized light microscopy shows loss of birefringence in dag1 morphant myotomes (white arrowheads). Birefringence is rescued in NADþ-supplemented dag1
morphants. (B) 3 dpf embryos stained with phalloidin (white). Fiber detachment is readily observed in dag1 morphants (arrowheads). (C) NADþ supplementation reduces
ﬁber detachment in dag1 morphants. (D) Genetic mosaic cartoon depicting transplantation of ﬂuorescent dextran-labeled dag1 morphant (red) and control (blue) cells into
unlabeled, control hosts. Embryos were stressed (frequently stimulated to swim in a viscous medium), and reared to 3 dpf. (E) Transplanted control cells (blue) and dag1
morphant cells (red) remain attached to MTJs, even when hosts are stressed. This suggests that a normal host ECM microenvironment is sufﬁcient for resiliency of dag1
morphant cells and supports that NADþ functions via augmentation of the ECM microenvironment.
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yielded important pathological and therapeutic insights for UCMD
and Bethlam myopathy (e.g. identifying mitochondrial disruptions
(Irwin et al., 2003) and roles for autophagy in muscle homeostasis
(Grumati et al., 2010)); however, these mice failed to recapitulate
the severity of UCMD. This could potentially be due to the genetics
of the background strain used as discussed above for the mdx
mouse model of DMD. Recently, zebraﬁsh models of UCMD and
Bethlam myopathy were generated using morpholinos to block the
incorporation of exon 9 or 13 of col6a1, respectively (Telfer et al.,
2010). Injection of the morpholino targeting exon 9 produced early
onset disruptions to muscle architecture, mitochondria, and moti-
lity in zebraﬁsh. Mitochondria morphology and embryo motility
could be rescued by a drug inhibiting the mitochondrial perme-
ability transition pore (Telfer et al., 2010), similar to what was seen
in col6a1 mutant mice (Irwin et al., 2003). Despite these important
insights into collagen function, the cellular adaptive responses to
collagen disruptions are just beginning to be uncovered in multiple
tissues. Is there any functional redundancy or the potential for
compensation between various collagen molecules in the muscle
ECM? Could muscle ECM molecules regulating collagen processes
be manipulated to improve disease symptoms? There does not
appear to be compensation between type XV and XVIII collagens,
despite similar structures and tissue expression, because double
mutant mice do not display any novel, major defects compared to
single mutants (Ylikärppä et al., 2003). In contrast, double knock
out of two proteoglycans (Decorin and Biglycan) that each regulate
collagen ﬁbril formation by competing for the same binding site in
type I collagen (Pogány et al., 1994) resulted in more severe bone
(Young et al., 2002) and corneal (Zhang et al., 2009) phenotypes in
mice than knock out of either alone, suggesting redundancy and
compensation between Decorin and Biglycan in collagen regulation
in these tissues. Finally, in col4a3 mutant mice modeling Alport
Syndrome, which affects the kidney glomerular BM, expression of
col4a1, col4a2, lama1, and lama5 either persist or are upregulated in
the glomerular BM (Abrahamson et al., 2007). Whether there is
compensation between different collagen molecules in muscle
tissue or whether collagen disruptions can be compensated for by
changes to other muscle ECM proteins or receptors in animal
models of UCMD or Bethlam myopathy remain to be tested and
could provide important therapeutic insights for these muscle
diseases and potentially other muscle pathologies as well.
Conclusions
It has become increasingly clear that signaling pathways
mediating embryonic development also can regulate homeostasis
and aging. Cell–ECM adhesion interacts with these pathways
throughout the lifespan. We believe muscle is a robust and
strategic tissue for interrogating these interactions and that these
interactions contain tremendous potential for therapeutic discov-
eries. As we begin to understand the foundations of adhesion-
dependent adaptive cellular responses, we will be exploring the
innate ability of tissue to maintain homeostasis and repair its own
damage, rather than treating downstream symptoms. The promise
of regenerative medicine will likely require a clear and mechan-
istic understanding of how cell–ECM interactions potentiate
robust cellular adaptation to stresses so that these intrinsic
responses can be exploited for therapeutic purposes.
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